Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Tan Sheet

Executive Summary

Weinberg succeeds Dehecq as Sanofi chairman: The Sanofi-Aventis board appoints Serge Weinberg chairman to succeed Jean Francois Dehecq, who resigns his board duties but will serve as honorary board chairman and as president of the newly formed Sanofi Espoir Foundation, which supports implementing health and solidarity programs worldwide. In a May 17 release, Dehecq said he leaves the chairman post after record revenue year for the firm and "with confidence in the collaboration of Serge Weinberg and [CEO] Chris Viehbacher to lead Sanofi-Aventis to further successes." Sanofi, which expects to double its OTC segment's size in five years through acquisitions by 2014, made an offer for Polish consumer product firm Nepentes. The firm's consumer health care business grew 42.5 percent to $661.1 million in most recent quarter (see story p. 6)

You may also be interested in...



People In Brief

NIH, FDA vet leads MusclePharm research

People In Brief

NIH, FDA vet leads MusclePharm research

People In Brief

NIH, FDA vet leads MusclePharm research

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS104143

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel